See more : Spencer Pharmaceutical Inc. (SPPH) Income Statement Analysis – Financial Results
Complete financial analysis of Unidoc Health Corp. (UDOC.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Unidoc Health Corp., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Jiangsu Huachang Chemical Co., Ltd. (002274.SZ) Income Statement Analysis – Financial Results
- PT Midi Utama Indonesia Tbk (MIDI.JK) Income Statement Analysis – Financial Results
- The Metal Arts Company, Inc. (MTRT) Income Statement Analysis – Financial Results
- Modiv Inc. (MDV-PA) Income Statement Analysis – Financial Results
- 5E Advanced Materials Inc. (FEAM) Income Statement Analysis – Financial Results
Unidoc Health Corp. (UDOC.CN)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.unidoctor.com
About Unidoc Health Corp.
UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It offers Virtual Health Clinics, a customizable solution that offers safe and secure ways to connect patients in urban, rural, and remote locations with medical care, as well as delivers rapid and real-time diagnostic testing, and supplies therapeutic treatment with continued health monitoring. The company was formerly known as Unicheck Holdings Corp. and changed its name to UniDoc Health Corp. in April 2021. UniDoc Health Corp. was incorporated in 2021 and is based in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 68.26K | 64.22K | 15.25K | 0.00 |
| Gross Profit | -68.26K | -64.22K | -15.25K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 17.65K | 12.09K | 353.02K | 0.00 |
| General & Administrative | 0.00 | 893.51K | 2.19M | 0.00 |
| Selling & Marketing | 0.00 | 211.37K | 448.99K | 0.00 |
| SG&A | 2.11M | 1.10M | 2.63M | 237.32K |
| Other Expenses | 0.00 | 35.00K | 0.00 | 0.00 |
| Operating Expenses | 2.13M | 1.35M | 3.00M | 237.32K |
| Cost & Expenses | 2.20M | 1.35M | 3.00M | 237.32K |
| Interest Income | 1.40K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.68K | 9.08K | 1.77K | 0.00 |
| Depreciation & Amortization | 68.26K | 64.22K | 15.25K | 206.30K |
| EBITDA | -2.18M | -1.26M | -2.99M | -237.32K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.20M | -1.32M | -3.00M | -237.32K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -59.20K | -37.23K | -1.98K | -2.00 |
| Income Before Tax | -2.26M | -1.36M | -3.00M | -237.32K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -1.00 | 44.08K | 1.77K | -206.30K |
| Net Income | -2.26M | -1.36M | -3.00M | -237.32K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.06 | -0.14 | 0.00 |
| EPS Diluted | -0.04 | -0.06 | -0.14 | 0.00 |
| Weighted Avg Shares Out | 50.34M | 21.87M | 21.87M | 84.91M |
| Weighted Avg Shares Out (Dil) | 50.34M | 21.87M | 21.87M | 84.91M |
Source: https://incomestatements.info
Category: Stock Reports